Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2

• Main Authors: Byung Soo Kim (Author), Seong Jin Jo (Author), SangWoong Youn (Author), Kristian Reich (Author), Carine Saadoun (Author), Chia-Ling Chang (Author), Ya-Wen Yang (Author), Yu-Huei Huang (Author), Tsen-Fang Tsai (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Guselkumab is a human monoclonal antibody against IL-23 used in the treatment of moderate-to-severe psoriasis. This post-hoc analysis evaluated the efficacy and safety of guselkumab in the Asian subpopulation of VOYAGE 1 and VOYAGE 2 through 5 years. Methods The proportions of...